APA (7th ed.) Citation

NQ, L., I, P., L, C., P, Z., H, T., D, A., . . . J, D. (2023). SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors. Nature communications, 14(1), 7762. https://doi.org/10.1038/s41467-023-43498-3

Chicago Style (17th ed.) Citation

NQ, Liu, et al. "SMARCB1 Loss Activates Patient-specific Distal Oncogenic Enhancers in Malignant Rhabdoid Tumors." Nature Communications 14, no. 1 (2023): 7762. https://doi.org/10.1038/s41467-023-43498-3.

MLA (9th ed.) Citation

NQ, Liu, et al. "SMARCB1 Loss Activates Patient-specific Distal Oncogenic Enhancers in Malignant Rhabdoid Tumors." Nature Communications, vol. 14, no. 1, 2023, p. 7762, https://doi.org/10.1038/s41467-023-43498-3.